Correlation Between ABVC Biopharma and Diffusion Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Diffusion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Diffusion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and Diffusion Pharmaceuticals, you can compare the effects of market volatilities on ABVC Biopharma and Diffusion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Diffusion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Diffusion Pharmaceuticals.

Diversification Opportunities for ABVC Biopharma and Diffusion Pharmaceuticals

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between ABVC and Diffusion is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Diffusion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diffusion Pharmaceuticals and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Diffusion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diffusion Pharmaceuticals has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Diffusion Pharmaceuticals go up and down completely randomly.

Pair Corralation between ABVC Biopharma and Diffusion Pharmaceuticals

Given the investment horizon of 90 days ABVC Biopharma is expected to generate 2.48 times more return on investment than Diffusion Pharmaceuticals. However, ABVC Biopharma is 2.48 times more volatile than Diffusion Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Diffusion Pharmaceuticals is currently generating about -0.11 per unit of risk. If you would invest  746.00  in ABVC Biopharma on August 29, 2024 and sell it today you would lose (695.00) from holding ABVC Biopharma or give up 93.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy31.45%
ValuesDaily Returns

ABVC Biopharma  vs.  Diffusion Pharmaceuticals

 Performance 
       Timeline  
ABVC Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABVC Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Diffusion Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Diffusion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Diffusion Pharmaceuticals is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

ABVC Biopharma and Diffusion Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ABVC Biopharma and Diffusion Pharmaceuticals

The main advantage of trading using opposite ABVC Biopharma and Diffusion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Diffusion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diffusion Pharmaceuticals will offset losses from the drop in Diffusion Pharmaceuticals' long position.
The idea behind ABVC Biopharma and Diffusion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Correlations
Find global opportunities by holding instruments from different markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing